Takahisa Yamada Selected Research

Takahisa Yamada Research Topics

Disease

42	Heart Failure 01/2022 - 01/2003
10	Type 2 Diabetes Mellitus (MODY) 01/2021 - 12/2003
8	Atrial Fibrillation 12/2022 - 11/2015
6	Diabetes Mellitus 01/2021 - 01/2008
5	Chronic Renal Insufficiency 01/2022 - 10/2008
5	Obesity 01/2022 - 12/2003
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 04/2016
4	Hypertension (High Blood Pressure) 01/2021 - 02/2013
4	Hyperglycemia 06/2018 - 04/2008
3	Infections 12/2022 - 05/2015
3	Inflammation (Inflammations) 01/2021 - 06/2018
3	Fibrosis (Cirrhosis) 01/2021 - 10/2017
3	Malnutrition (Nutritional Deficiencies) 01/2021 - 01/2019
3	Body Weight (Weight, Body) 01/2020 - 08/2015
3	Ventricular Tachycardia 12/2019 - 12/2015
3	Cardiac Sudden Death (Sudden Cardiac Arrest) 02/2019 - 02/2009
2	Death (Near-Death Experience) 01/2022 - 04/2015
2	Left Ventricular Dysfunction 01/2021 - 02/2009
2	Anemia 01/2021 - 03/2020
2	Insulin Resistance 10/2019 - 01/2008
2	Dyslipidemias (Dyslipidemia) 01/2019 - 01/2008
2	Wounds and Injuries (Trauma) 02/2018 - 05/2015
2	ST Elevation Myocardial Infarction 01/2018 - 06/2016
2	Myocardial Infarction 08/2017 - 06/2016
1	Cardiac Arrhythmias (Arrythmia) 12/2022
1	Abdominal Obesity 01/2022
1	Neointima 08/2021
1	Experimental Arthritis 03/2021
1	Rheumatoid Arthritis 03/2021
1	Osteoporosis 03/2021
1	Atrophy 01/2021
1	Atherosclerosis 01/2021
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 03/2020
1	Weight Loss (Weight Reduction) 01/2020
1	Body Weight Changes 01/2020
1	Endocarditis 11/2019
1	Meningitis 11/2019
1	Respiratory Insufficiency (Respiratory Failure) 11/2019
1	Septic Shock (Toxic Shock Syndrome) 11/2019
1	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2019

Drug/Important Bio-Agent (IBA)

14	3-Iodobenzylguanidine (Iobenguane)IBA 01/2022 - 01/2003
10	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 01/2019
8	Iodine-123IBA 01/2022 - 01/2003
6	Glucose (Dextrose)FDA LinkGeneric 10/2019 - 08/2007
5	C-Reactive ProteinIBA 12/2022 - 01/2019
5	pro-brain natriuretic peptide (1-76)IBA 01/2021 - 07/2020
4	Eplerenone (Inspra)FDA LinkGeneric 01/2022 - 04/2015
3	CholesterolIBA 01/2021 - 08/2015
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 12/2006
2	CreatinineIBA 01/2022 - 10/2008
2	Mineralocorticoid Receptor AntagonistsIBA 01/2022 - 04/2016
2	Blood Glucose (Blood Sugar)IBA 01/2022 - 01/2011
2	Urea (Carbamide)FDA LinkGeneric 01/2022 - 01/2019
2	NitrogenIBA 01/2022 - 01/2019
2	ChloridesIBA 01/2022 - 01/2018
2	Triglycerides (Triacylglycerol)IBA 01/2022 - 08/2015
2	LipidsIBA 08/2021 - 06/2018
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2021 - 10/2019
2	AlbuminsIBA 07/2020 - 01/2019
2	DiureticsIBA 01/2020 - 04/2017
2	Tolvaptan FDA Link 01/2020 - 04/2017
2	Cholinesterases (Cholinesterase)IBA 01/2020 - 01/2019
2	Pharmaceutical PreparationsIBA 10/2019 - 12/2017
2	Metformin (Glucophage)FDA LinkGeneric 06/2018 - 12/2017
2	Radioisotopes (Radionuclides)IBA 06/2013 - 10/2004
2	Sodium Bicarbonate (Baking Soda)FDA LinkGeneric 04/2011 - 10/2008
2	Lipase (Acid Lipase)FDA Link 01/2008 - 06/2005
2	Atorvastatin (Lipitor)FDA Link 06/2007 - 12/2006
1	BilirubinIBA 12/2022
1	tyramine-deoxysorbitolIBA 01/2022
1	TransferasesIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 04/2021
1	JTP-117968IBA 03/2021
1	GlucocorticoidsIBA 03/2021
1	LipopolysaccharidesIBA 03/2021
1	HDL CholesterolIBA 01/2021
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2021
1	CanagliflozinIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2021
1	Serum AlbuminIBA 01/2021
1	dimemorfan (AT 17)IBA 01/2021
1	oleoylethanolamideIBA 01/2021
1	empagliflozinIBA 01/2021
1	ferric citrateIBA 03/2020
1	Phosphorus (Red Phosphorus)IBA 03/2020
1	Phosphates (Orthophosphate)IBA 03/2020
1	IronIBA 03/2020
1	Amiodarone (Amiodarona)FDA LinkGeneric 11/2019
1	SteroidsIBA 11/2019
1	Angiotensin Receptor AntagonistsIBA 01/2019

Therapy/Procedure

8	Therapeutics 01/2021 - 12/2006
4	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 12/2019 - 09/2012
3	Percutaneous Coronary Intervention 01/2018 - 06/2016
2	Patient Readmission 10/2021 - 07/2020
2	Catheter Ablation 01/2020 - 11/2015
1	Telerehabilitation 01/2021
1	Cardiac Rehabilitation 01/2021
1	Oral Administration 03/2020
1	Punctures 11/2019